VOYA Investment Management Portfolio holdings
AUM
$100B
This Quarter Return
+7.75%
1 Year Return
+30.07%
3 Year Return
+120.64%
5 Year Return
+214.86%
10 Year Return
+564.47%
AUM
$48.6B
AUM Growth
+$48.6B
(+3.3%)
Cap. Flow
-$1.54B
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
16.48%
Holding
2,644
New
42
Increased
562
Reduced
1,043
Closed
62
Top Buys
| 1 |
Biogen
BIIB
|
$292M |
| 2 |
Honeywell
HON
|
$182M |
| 3 |
Altria Group
MO
|
$165M |
| 4 |
W.W. Grainger
GWW
|
$162M |
| 5 |
Electronic Arts
EA
|
$154M |
Top Sells
| 1 |
LLL
L3 Technologies, Inc.
LLL
|
$281M |
| 2 |
Zoetis
ZTS
|
$218M |
| 3 |
Broadcom
AVGO
|
$179M |
| 4 |
Parker-Hannifin
PH
|
$172M |
| 5 |
Amphenol
APH
|
$171M |
Sector Composition
| 1 | Technology | 20.5% |
| 2 | Healthcare | 14.06% |
| 3 | Consumer Discretionary | 12.93% |
| 4 | Industrials | 12.84% |
| 5 | Financials | 12.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INST
276
DELISTED
Instructure, Inc.
INST
| $35.4M | 0.07% | 1,000,327 +515,005 | +106% | +$18.2M |
|
|
FNSR
277
DELISTED
Finisar Corp
FNSR
| $35.3M | 0.07% | 1,853,276 +130,740 | +8% | +$2.49M |
|
278
Paylocity
PCTY
$9.89B
| $35M | 0.07% | 436,312 -9,976 | -2% | -$801K |
|
|
CELG
279
DELISTED
Celgene Corp
CELG
| $35M | 0.07% | 391,358 -151,856 | -28% | -$13.6M |
|
|
ARRY
280
DELISTED
Array Biopharma Inc
ARRY
| $35M | 0.07% | 2,301,455 +301,965 | +15% | +$4.59M |
|
|
UNT
281
DELISTED
UNIT Corporation
UNT
| $35M | 0.07% | 1,341,438 -200,614 | -13% | -$5.23M |
|
282
Etsy
ETSY
$5.25B
| $34.6M | 0.07% | 674,267 +625,869 | +1,293% | +$32.2M |
|
283
Enpro
NPO
$4.57B
| $34.5M | 0.07% | 473,555 -10,173 | -2% | -$742K |
|
|
ABMD
284
DELISTED
Abiomed Inc
ABMD
| $34.2M | 0.07% | 76,053 -23,811 | -24% | -$10.7M |
|
|
ESRX
285
DELISTED
Express Scripts Holding Company
ESRX
| $33.9M | 0.07% | 357,101 -155,836 | -30% | -$14.8M |
|
286
Marriott International Class A Common Stock
MAR
$72.7B
| $33.8M | 0.07% | 255,872 +257 | +0.1% | +$33.9K |
|
287
Stifel
SF
$11.8B
| $33.8M | 0.07% | 658,394 +155,868 | +31% | +$7.99M |
|
288
Boise Cascade
BCC
$3.25B
| $33.7M | 0.07% | 916,054 +8,360 | +0.9% | +$308K |
|
289
Pinnacle Financial Partners
PNFP
$7.54B
| $33.6M | 0.07% | 558,049 -83,697 | -13% | -$5.03M |
|
290
Timken Company
TKR
$5.38B
| $33.5M | 0.07% | 671,689 -76,619 | -10% | -$3.82M |
|
|
291
Zoetis
ZTS
$69.3B
| $33.4M | 0.07% | 364,368 -2,375,855 | -87% | -$218M |
|
292
Supernus Pharmaceuticals
SUPN
$2.53B
| $33.3M | 0.07% | 660,406 +75,087 | +13% | +$3.78M |
|
293
Allstate
ALL
$53.6B
| $33.1M | 0.07% | 335,725 -3,486 | -1% | -$344K |
|
294
Danaher
DHR
$147B
| $32.9M | 0.07% | 302,997 -10,448 | -3% | -$1.14M |
|
295
Primerica
PRI
$8.72B
| $32.8M | 0.07% | 272,077 -365,306 | -57% | -$44M |
|
296
Lumentum
LITE
$9.28B
| $32.6M | 0.07% | 544,143 +518,833 | +2,050% | +$31.1M |
|
297
Bank of New York Mellon
BK
$74.5B
| $32.2M | 0.07% | 632,084 -15,595 | -2% | -$795K |
|
298
Compass Minerals
CMP
$794M
| $32.2M | 0.07% | 478,630 +32,160 | +7% | +$2.16M |
|
|
LOXO
299
DELISTED
Loxo Oncology, Inc
LOXO
| $32.1M | 0.07% | 187,934 +1,512 | +0.8% | +$258K |
|
300
Consolidated Edison
ED
$35.4B
| $32M | 0.07% | 420,249 -21,392 | -5% | -$1.63M |
|